“…Moreover, cGAS has a wide cellular distribution that involves localization at the inner leaflet of the plasma membrane, cytoplasm, and nucleus ( Sun et al., 2013 ; Barnett et al., 2019 ; Jiang et al., 2019 ). Multifaceted safeguard mechanisms have been adopted by the host to prevent aberrant cGAS‒STING signaling-induced autoreactivity under steady-state conditions, which include (i) segregation of cGAS away from extracellular DNA and mtDNA via compartmentalization of cGAS to the cytosol and the inner plasma membrane, (ii) tight tethering of nuclear cGAS by histones to prevent cGAS activation by genomic DNA ( Boyer et al., 2020 ; Kujirai et al., 2020 ; Michalski et al., 2020 ; Pathare et al., 2020 ; Zhao et al., 2020a ), (iii) nucleases and phosphodiesterases that degrade immunogenic DNA and 2′3′-cGAMP ( Li et al., 2014 ; Motwani et al., 2019b ), and (iv) sophisticated protein‒protein interaction and posttranslational modification (PTM) networks to maintain the stability and functionality of cGAS and STING ( Hertzog and Rehwinkel, 2020 ; Hong et al., 2021a ). Disrupting one piece of these regulatory mechanisms leads to the imbalance of cGAS‒STING signaling that induces or aggregates multiple sterile inflammatory diseases, including autoimmune diseases, neurodegenerative diseases, metabolic disorders, and cancers ( Bai and Liu, 2019 ; Motwani et al., 2019b ; Paul et al., 2020 ).…”